{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antiviral activity", "COVID-19", "SARS-CoV-2", "medicinal plant"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35894129", "DateCompleted": {"Year": "2022", "Month": "11", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "07", "Day": "27"}], "Language": ["eng"], "ELocationID": ["10.1177/15353702221108915"], "Journal": {"ISSN": "1535-3699", "JournalIssue": {"Volume": "247", "Issue": "20", "PubDate": {"Year": "2022", "Month": "Oct"}}, "Title": "Experimental biology and medicine (Maywood, N.J.)", "ISOAbbreviation": "Exp Biol Med (Maywood)"}, "ArticleTitle": "Antiviral activity of medicinal plant-derived products against SARS-CoV-2.", "Pagination": {"StartPage": "1797", "EndPage": "1809", "MedlinePgn": "1797-1809"}, "Abstract": {"AbstractText": ["This review presents information from several studies that have demonstrated the antiviral activity of extracts (<i>Andrographis paniculata</i>, <i>Artemisia annua</i>, <i>Artemisia afra</i>, <i>Cannabis sativa</i>, <i>Curcuma longa</i>, <i>Echinacea purpurea</i>, <i>Olea europaea</i>, <i>Piper nigrum</i>, and <i>Punica granatum</i>) and phytocompounds derived from medicinal plants (artemisinins, glycyrrhizin, and phenolic compounds) against SARS-CoV-2. A brief background of the plant products studied, the methodology used to evaluate the antiviral activity, the main findings from the research, and the possible mechanisms of action are presented. These plant products have been shown to impede the adsorption of SARS-CoV-2 to the host cell, and prevent multiplication of the virus post its entry into the host cell. In addition to antiviral activity, the plant products have also been demonstrated to exert an immunomodulatory effect by controlling the excessive release of cytokines, which is commonly associated with SARS-CoV-2 infections."]}, "AuthorList": [{"Identifier": ["0000-0003-2398-6506"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Anhembi Morumbi University (UAM), Avenida Deputado Benedito Matarazzo, 6707 - Jardim Aquarius, S\u00e3o Jos\u00e9 dos Campos 12242-010, SP, Brazil."}], "LastName": "de Oliveira", "ForeName": "Jonatas Rafael", "Initials": "JR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Anhembi Morumbi University (UAM), Avenida Deputado Benedito Matarazzo, 6707 - Jardim Aquarius, S\u00e3o Jos\u00e9 dos Campos 12242-010, SP, Brazil."}], "LastName": "Antunes", "ForeName": "Beatriz Sales", "Initials": "BS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Anhembi Morumbi University (UAM), Avenida Deputado Benedito Matarazzo, 6707 - Jardim Aquarius, S\u00e3o Jos\u00e9 dos Campos 12242-010, SP, Brazil."}], "LastName": "do Nascimento", "ForeName": "Gabriela Oliveira", "Initials": "GO"}, {"Identifier": ["0000-0001-9932-6761"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Anhembi Morumbi University (UAM), Avenida Deputado Benedito Matarazzo, 6707 - Jardim Aquarius, S\u00e3o Jos\u00e9 dos Campos 12242-010, SP, Brazil."}], "LastName": "Kawall", "ForeName": "Jaqueline Cadorini de Souza", "Initials": "JCS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Anhembi Morumbi University (UAM), Avenida Deputado Benedito Matarazzo, 6707 - Jardim Aquarius, S\u00e3o Jos\u00e9 dos Campos 12242-010, SP, Brazil."}], "LastName": "Oliveira", "ForeName": "Jo\u00e3o Victor Bianco", "Initials": "JVB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Anhembi Morumbi University (UAM), Avenida Deputado Benedito Matarazzo, 6707 - Jardim Aquarius, S\u00e3o Jos\u00e9 dos Campos 12242-010, SP, Brazil."}], "LastName": "Silva", "ForeName": "Kevin Gustavo Dos Santos", "Initials": "KGDS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Anhembi Morumbi University (UAM), Avenida Deputado Benedito Matarazzo, 6707 - Jardim Aquarius, S\u00e3o Jos\u00e9 dos Campos 12242-010, SP, Brazil."}], "LastName": "Costa", "ForeName": "Mariana Aparecida de Toledo", "Initials": "MAT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Anhembi Morumbi University (UAM), Avenida Deputado Benedito Matarazzo, 6707 - Jardim Aquarius, S\u00e3o Jos\u00e9 dos Campos 12242-010, SP, Brazil."}, {"Identifier": [], "Affiliation": "Post-graduation Program in Biomedical Engineering, Federal University of Sao Paulo (UNIFESP), Rua Talim, 330 - Vila Nair, S\u00e3o Jos\u00e9 dos Campos 12231-280, SP, Brazil."}], "LastName": "Oliveira", "ForeName": "Carlos Rocha", "Initials": "CR"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Exp Biol Med (Maywood)", "NlmUniqueID": "100973463", "ISSNLinking": "1535-3699"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Artemisinins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Artemisinins"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J Clin Med 2020;9:1225", "ArticleIdList": ["PMC7230578", "32344679"]}, {"Citation": "Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 2015;28:465\u2013522", "ArticleIdList": ["PMC4402954", "25810418"]}, {"Citation": "Huang JT, Ran RX, Lv ZH, Feng LN, Ran CY, Tong YQ, Li D, Su HW, Zhu CL, Qiu SL, Yang J, Xiao MY, Liu MJ, Yang YT, Liu SM, Li Y. Chronological changes of viral shedding in adult inpatients with COVID-19 in Wuhan, China. Clin Infect Dis 2020;71:2158\u201366", "ArticleIdList": ["PMC7314240", "32445580"]}, {"Citation": "Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536\u201344", "ArticleIdList": ["PMC7095448", "32123347"]}, {"Citation": "Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. J Pathol 2004;203:631\u20137", "ArticleIdList": ["PMC7167720", "15141377"]}, {"Citation": "Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS;, China Medical Treatment Expert Group for Covid-19 . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708\u201320", "ArticleIdList": ["PMC7092819", "32109013"]}, {"Citation": "Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de, Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, F\u00e4tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC;, ACTT-1 Study Group Members. Remdesivir for the treatment of COVID-19: final report. N Engl J Med 2020;383:1813\u201326", "ArticleIdList": ["PMC7262788", "32445440"]}, {"Citation": "Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, Avezum A, Lopes RD, Bueno FR, Silva MVAO, Baldassare FP, Costa ELV, Moura RAB, Honorato MO, Costa AN, Damiani LP, Lisboa T, Kawano-Dourado L, Zampieri FG, Olivato GB, Righy C, Amendola CP, Roepke RML, Freitas DHM, Forte DN, Freitas FGR, Fernandes CCF, Melro LMG, Junior GFS, Morais DC, Zung S, Machado FR, Azevedo LCP; COALITION COVID-19 Brazil III, Investigators. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA 2020;324:1307\u201316", "ArticleIdList": ["PMC7489411", "32876695"]}, {"Citation": "Dequin PF, Heming N, Meziani F, Plantef\u00e8ve G, Voiriot G, Badi\u00e9 J, Fran\u00e7ois B, Aubron C, Ricard JD, Ehrmann S, Jouan Y, Guillon A, Leclerc M, Coffre C, Bourgoin H, Lengell\u00e9 C, Caille-F\u00e9n\u00e9rol C, Tavernier E, Zohar S, Giraudeau B, Annane D, Le Gouge A, CAPE COVID Trial Group the CRICS-TriGGERSep Network . Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial. JAMA 2020;324:1298\u20131206", "ArticleIdList": ["PMC7489432", "32876689"]}, {"Citation": "Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269\u201371", "ArticleIdList": ["PMC7054408", "32020029"]}, {"Citation": "Kamboj A, Saluja AK, Kumar M, Atri P. Antiviral activity of plant polyphenols. J Pharm Res 2012;5:2402\u201312"}, {"Citation": "Pholphana N, Rangkadilok N, Saehun J, Ritruechai S, Satayavivad J. Changes in the contents of four active diterpenoids at different growth stages in Andrographis paniculata (Burm.f.) Nees (Chuanxinlian). Chin Med 2013;8:2.", "ArticleIdList": ["PMC3552871", "23320627"]}, {"Citation": "Hossain MS, Urbi Z, Sule A, Hafizur Rahman KM. Andrographis paniculata (Burm.f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology. Sci World J 2014;2014:274905", "ArticleIdList": ["PMC4408759", "25950015"]}, {"Citation": "Koteswara Rao Y, Vimalamma G, Rao CV, Tzeng YM. Flavonoids and andrographolides from Andrographis paniculata. Phytochemistry 2004;65:2317\u201321", "ArticleIdList": ["15381002"]}, {"Citation": "Gupta S, Mishra KP, Ganju L. Broad-spectrum antiviral properties of andrographolide. Arch Virol 2017;162:611\u201323", "ArticleIdList": ["27896563"]}, {"Citation": "Shi TH, Huang YL, Chen CC, Pi WC, Hsu YL, Lo LC, Chen WY, Fu SL, Lin CH. Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage. Biochem Biophys Res Commun 2020;533:467\u201373", "ArticleIdList": ["PMC7447262", "32977949"]}, {"Citation": "Sa-Ngiamsuntorn K, Suksatu A, Pewkliang Y, Thongsri P, Kanjanasirirat P, Manopwisedjaroen S, Charoensutthivarakul S, Wongtrakoongate P, Pitiporn S, Chaopreecha J, Kongsomros S, Jearawuttanakul K, Wannalo W, Khemawoot P, Chutipongtanate S, Borwornpinyo S, Thitithanyanont A, Hongeng S. Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. J Nat Prod 2021;84:1261\u201370", "ArticleIdList": ["33844528"]}, {"Citation": "Simon JE, Charles D, Cebert E, Grant L, Janick J, Whipkey A. Artemisia annua L.: a promising aromatic and medicinal. In: Janick J, Simon JE. Advances in new crops. Portland, OR: Timber Press, 1990, pp.522\u20136."}, {"Citation": "Brown GD. The biosynthesis of artemisinin (Qinghaosu) and the phytochemistry of Artemisia annua L. (Qinghao). Molecules 2010;15:7603\u201398", "ArticleIdList": ["PMC6259225", "21030913"]}, {"Citation": "Garcia LC. A Review of Artemisia annua L.: its genetics, biochemical characteristics, and anti-malarial efficacy. Int J Sci Tech 2015;5:38\u201346"}, {"Citation": "Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, Zhang X, Hua SN, Yu J, Xiao PG, Li RS, Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005;67:18\u201323", "ArticleIdList": ["PMC7114104", "15885816"]}, {"Citation": "Nair MS, Huang Y, Fidock DA, Polyak SJ, Wagoner J, Towler MJ, Weathers PJ. Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants. J Ethnopharmacol 2021;274:114016.", "ArticleIdList": ["PMC7952131", "33716085"]}, {"Citation": "\nJohnson TO, Adegboyega AE, Ojo AO, Yusuf AJ, Iwaloye O, Ugwah-Oguejiofor CJ, Asomadu RO, Chukwuma IF, Ejembi SA, Ugwuja EI.\nIdentification of possible inhibitors of SARS-CoV-2 main protease from some bioactive compounds of Artemisia annua: an in silico approach.\nResearch Square\n2021, https://assets.researchsquare.com/files/rs-612899/v2/d211f386-6f3b-4c80-80a0-2dd80698f000.pdf?c=1637245461"}, {"Citation": "Fuzimoto AD. An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment. J Integr Med 2021;19:375\u201388", "ArticleIdList": ["PMC8378675", "34479848"]}, {"Citation": "Klayman DL. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985;228:1049\u201355", "ArticleIdList": ["3887571"]}, {"Citation": "Adam I, Elhardello OA, Elhadi MO, Abdalla E, Elmardi KA, Jansen FH. The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria. Ann Trop Med Parasitol 2008;102:39\u201344", "ArticleIdList": ["18186976"]}, {"Citation": "Efferth T. From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol 2017;46:65\u201383", "ArticleIdList": ["28254675"]}, {"Citation": "Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJ, Marschall M. The antiviral activities of artemisinin and artesunate. Clin Infect Dis 2008;47:804\u201311", "ArticleIdList": ["18699744"]}, {"Citation": "Zhou Y, Gilmore K, Ramirez S, Settels E, Gammeltoft KA, Pham LV, Fahn\u00f8e U, Feng S, Offersgaard A, Trimpert J, Bukh J, Osterrieder K, Gottwein JM, Seeberger PH. In vitro efficacy of artemisinin-based treatments against SARS-CoV-2. Sci Rep 2021;11:14571.", "ArticleIdList": ["PMC8285423", "34272426"]}, {"Citation": "Dandara C, Dzobo K, Chirikure S. COVID-19 Pandemic and Africa: from the situation in Zimbabwe to a case for precision herbal medicine. OMICS 2021;25:209\u201312", "ArticleIdList": ["32654634"]}, {"Citation": "Nie C, Trimpert J, Moon S, Haag R, Gilmore K, Kaufer BB, Seeberger PH. In vitro efficacy of artemisia extracts against SARS-CoV-2. Virol J 2021;18:182.", "ArticleIdList": ["PMC8424155", "34496903"]}, {"Citation": "Costa MS, Kiralj R, Ferreia MMC. Theoretical study of the interaction between artemisinin and heme. Quim Nova 2007;30:25\u201331"}, {"Citation": "Ho WE, Peh HY, Chan TK, Wong WS. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther 2014;142:126\u201339", "ArticleIdList": ["24316259"]}, {"Citation": "Cheong DHJ, Tan DWS, Wong FWS, Tran T. Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases. Pharmacol Res 2020;158:104901.", "ArticleIdList": ["PMC7217791", "32405226"]}, {"Citation": "Cao R, Hu H, Li Y, Wang X, Xu M, Liu J, Zhang H, Yan Y, Zhao L, Li W, Zhang T, Xiao D, Guo X, Li Y, Yang J, Hu Z, Wang M, Zhong W. Anti-SARS-CoV-2 potential of artemisinins in vitro. ACS Infect Dis 2020;6:2524\u201331", "ArticleIdList": ["32786284"]}, {"Citation": "Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial (Erratum in Lancet 2020;395:1694). Lancet 2020;395:1569.", "ArticleIdList": ["PMC7190303", "32423584"]}, {"Citation": "Wang B, Kovalchuk A, Li D, Rodriguez-Juarez R, Ilnytskyy Y, Kovalchuk I, Kovalchuk O. In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues. Aging 2020;12:22425\u201344", "ArticleIdList": ["PMC7746344", "33221759"]}, {"Citation": "Fitzcharles MA, Clauw DJ, Hauser W. A cautious hope for cannabidiol (CBD) in rheumatology care. Arthritis Care Res. Epub ahead of print 7 March 2020. DOI: 10.1002/acr.24176.", "ArticleIdList": ["10.1002/acr.24176.", "32144889"]}, {"Citation": "Kovalchuk O, Kovalchuk I. Cannabinoids as anticancer therapeutic agents. Cell Cycle 2020;19:961\u201389", "ArticleIdList": ["PMC7217364", "32249682"]}, {"Citation": "H\u00e4user W, Finn DP, Kalso E, Krcevski-Skvarc N, Kress HG, Morlion B, Perrot S, Sch\u00e4fer M, Wells C, Brill S. European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. Eur J Pain 2018;22: 1547\u201364", "ArticleIdList": ["30074291"]}, {"Citation": "Fitzcharles MA, Niaki OZ, Hauser W, Hazlewood G, Canadian Rheumatology Association. Position statement: a pragmatic approach for medical cannabis and patients with rheumatic diseases. J Rheumatol 2019;46:532\u20138", "ArticleIdList": ["30647183"]}, {"Citation": "Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (COVID-19). J Clin Med 2020;9:841", "ArticleIdList": ["PMC7141517", "32244852"]}, {"Citation": "Stani\u0107 Z. Curcumin, a compound from natural sources, a true scientific challenge: a review. Plant Foods Hum Nutr 2017;72:1\u201312", "ArticleIdList": ["27995378"]}, {"Citation": "Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int 2014;2014:186864.", "ArticleIdList": ["PMC4022204", "24877064"]}, {"Citation": "Perrone D, Ardito F, Giannatempo G, Dioguardi M, Troiano G, Lo Russo L, DE Lillo A, Laino L, Lo Muzio L. Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med 2015;10: 1615\u201323", "ArticleIdList": ["PMC4665301", "26640527"]}, {"Citation": "Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol 2017;174:1325\u201348", "ArticleIdList": ["PMC5429333", "27638428"]}, {"Citation": "Anggakusuma Colpitts CC, Schang LM, Rachmawati H, Frentzen A, Pfaender S, Behrendt P, Brown RJ, Bankwitz D, Steinmann J, Ott M, Meuleman P, Rice CM, Ploss A, Pietschmann T, Steinmann E. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut 2014;63:1137\u201349", "ArticleIdList": ["23903236"]}, {"Citation": "Jennings MR, Parks RJ. Curcumin as ana Agent. Viruses 2020;12:1242", "ArticleIdList": ["PMC7693600", "33142686"]}, {"Citation": "Chen D, Shien J, Tiley L, Chiou S, Wang S, Chang T, Lee Y, WeiChan K, Hsu W. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem 2010;119:1346\u201351"}, {"Citation": "Bormann M, Alt M, Schipper L, van de Sand L, Le-Trilling VTK, Rink L, Heinen N, Madel RJ, Otte M, Wuensch K, Heilingloh CS, Mueller T, Dittmer U, Elsner C, Pfaender S, Trilling M, Witzke O, Krawczyk A. Turmeric root and its bioactive ingredient curcumin effectively neutralize SARS-CoV-2 in vitro. Viruses 2021;13:1914.", "ArticleIdList": ["PMC8537626", "34696344"]}, {"Citation": "Jena AB, Kanungo N, Nayak V, Chainy GBN, Dandapat J. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Sci Rep 2021;11:2043.", "ArticleIdList": ["PMC7820253", "33479401"]}, {"Citation": "Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64:353\u20136", "ArticleIdList": ["9619120"]}, {"Citation": "Larasati YA, Yoneda-Kato N, Nakamae I, Yokoyama T, Meiyanto E, Kato JY. Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth. Sci Rep 2018;8:2039.", "ArticleIdList": ["PMC5794879", "29391517"]}, {"Citation": "Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors 2013;39:69\u201377", "ArticleIdList": ["23281076"]}, {"Citation": "Mounce BC, Cesaro T, Carrau L, Vallet T, Vignuzzi M. Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antiviral Res 2017;142:148\u201357", "ArticleIdList": ["28343845"]}, {"Citation": "Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat 2014;46:2\u201318", "ArticleIdList": ["PMC3918523", "24520218"]}, {"Citation": "Roshdy WH, Rashed HA, Kandeil A, Mostafa A, Moatasim Y, Kutkat O, Abo Shama NM, Gomaa MR, El-Sayed IH, El Guindy NM, Naguib A, Kayali G, Ali MA. EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS ONE 2020;15:e0241739", "ArticleIdList": ["PMC7673558", "33206688"]}, {"Citation": "Pleschka S, Stein M, Schoop R, Hudson JB. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J 2009;6:197.", "ArticleIdList": ["PMC2785784", "19912623"]}, {"Citation": "Signer J, Jonsdottir HR, Albrich WC, Strasser M, Z\u00fcst R, Ryter S, Ackermann-G\u00e4umann R, Lenz N, Siegrist D, Suter A, Schoop R, Engler OB. In vitro virucidal activity of Echinaforce\u00ae, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2 (Erratum in: Virol J 2020;17:172). Virol J 2020;17:136.", "ArticleIdList": ["PMC7479405", "32907596"]}, {"Citation": "Schapowal A. The triple action of the herbal medicine Echinaforce in the treatment of cold and flu-like infections. Swiss J Integr Med 2011; 23:15"}, {"Citation": "Lim TK. Glycyrrhiza glabra. In: Lim TK. (ed.) Edible medicinal and non-medicinal plants. Dordrecht: Springer, 2016, pp.354\u201357"}, {"Citation": "van Gelderen CE, Bijlsma JA, van Dokkum W, Savelkoul TJ. Glycyrrhizic acid: the assessment of a no effect level. Hum Exp Toxicol 2000;19:434\u20139", "ArticleIdList": ["11125713"]}, {"Citation": "Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003;361:2045\u20136", "ArticleIdList": ["PMC7112442", "12814717"]}, {"Citation": "Huang W, Chen X, Li Q, Li P, Zhao G, Xu M, Xie P. Inhibition of intercellular adhesion in herpes simplex virus infection by glycyrrhizin. Cell Biochem Biophys 2012;62:137\u201340", "ArticleIdList": ["21874590"]}, {"Citation": "van de Sand L, Bormann M, Alt M, Schipper L, Heilingloh CS, Steinmann E, Todt D, Dittmer U, Elsner C, Witzke O, Krawczyk A. Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease. Viruses 2021;13:609.", "ArticleIdList": ["PMC8066091", "33918301"]}, {"Citation": "Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K, Liu F, Jiang R, Yang X, You T, Liu X, Yang X, Bai F, Liu H, Liu X, Guddat LW, Xu W, Xiao G, Qin C, Shi Z, Jiang H, Rao Z, Yang H. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 2020;582:289\u201393", "ArticleIdList": ["32272481"]}, {"Citation": "Soni MG, Burdock GA, Christian MS, Bitler CM, Crea R. Safety assessment of aqueous olive pulp extract as an antioxidant or antimicrobial agent in foods. Food Chem Toxicol 2006;44:903\u201315", "ArticleIdList": ["16530907"]}, {"Citation": "Karkovi\u0107 Markovi\u0107 A, Tori\u0107 J, Barbari\u0107 M, Jakobu\u0161i\u0107 Brala C. Hydroxytyrosol, tyrosol and derivatives and their potential effects on human health. Molecules 2019;24:2001", "ArticleIdList": ["PMC6571782", "31137753"]}, {"Citation": "Yamada K, Ogawa H, Hara A, Yoshida Y, Yonezawa Y, Karibe K, Nghia VB, Yoshimura H, Yamamoto Y, Yamada M, Nakamura K, Imai K. Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus. Antiviral Res 2009;83:35\u201344", "ArticleIdList": ["19501255"]}, {"Citation": "Bedoya LM, Beltr\u00e1n M, Obreg\u00f3n-Calder\u00f3n P, Garc\u00eda-P\u00e9rez J, de la Torre HE, Gonz\u00e1lez N, P\u00e9rez-Olmeda M, Au\u00f1\u00f3n D, Capa L, G\u00f3mez-Acebo E, Alcam\u00ed J. Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity. AIDS 2016;30:2767\u201376", "ArticleIdList": ["PMC5106087", "27677167"]}, {"Citation": "Christian MS, Sharper VA, Hoberman AM, Seng JE, Fu L, Covell D, Diener RM, Bitler CM, Crea R. The toxicity profile of hydrolyzed aqueous olive pulp extract. Drug Chem Toxicol 2004;27:309\u201330", "ArticleIdList": ["15573469"]}, {"Citation": "Bitler CM, Viale TM, Damaj B, Crea R. Hydrolyzed olive vegetation water in mice has anti-inflammatory activity. J Nutr 2005;135:1475\u20139", "ArticleIdList": ["15930455"]}, {"Citation": "Bitler CM, Matt K, Irving M, Hook G, Yusen J, Eagar F, Kirschner K, Walker B, Crea R. Olive extract supplement decreases pain and improves daily activities in adults with osteoarthritis and decreases plasma homocysteine in those with rheumatoid arthritis. Nutr Res 2007;27:470\u20137"}, {"Citation": "Di Rosa G, Brunetti G, Scuto M, Trovato Salinaro A, Calabrese EJ, Crea R, Schmitz-Linneweber C, Calabrese V, Saul N. Healthspan enhancement by olive polyphenols in C. Elegans Wild Type and Parkinson\u2019s Models. Int J Mol Sci 2020;21:3893", "ArticleIdList": ["PMC7312680", "32486023"]}, {"Citation": "Takeda Y, Jamsransuren D, Matsuda S, Crea R, Ogawa H. The SARS-CoV-2-inactivating activity of hydroxytyrosol-rich aqueous olive pulp extract (HIDROX\u00ae) and its use as a virucidal cream for topical application. Viruses 2021;13:232.", "ArticleIdList": ["PMC7913061", "33540713"]}, {"Citation": "Brudzynski K, Alvarez LM. Polyphenol\u2013protein complexes and their consequences for the redox activity, structure and function of honey: a current view and new hypothesis\u2014a review. Pol J Food Nutr Sci 2015;65:71\u201380"}, {"Citation": "Furukawa A, Oikawa S, Murata M, Hiraku Y, Kawanishi S. (\u2212)-Epigallocatechin gallate causes oxidative damage to isolated and cellular DNA. Biochem Pharmacol 2003;66:1769\u201378", "ArticleIdList": ["14563487"]}, {"Citation": "Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2009;2:270\u20138", "ArticleIdList": ["PMC2835915", "20716914"]}, {"Citation": "Patil UK, Saraogi R. Natural products as potential drug permeation enhancer in transdermal drug delivery system. Arch Dermatol Res 2014; 306:419\u201326", "ArticleIdList": ["24481830"]}, {"Citation": "Upadhyay S, Dixit M. Role of polyphenols and other phytochemicals on molecular signaling. Oxid Med Cell Longev 2015;2015:504253.", "ArticleIdList": ["PMC4477245", "26180591"]}, {"Citation": "Cory H, Passarelli S, Szeto J, Tamez M, Mattei J. The role of polyphenols in human health and food systems: a mini-review. Front Nutr 2018;5:87.", "ArticleIdList": ["PMC6160559", "30298133"]}, {"Citation": "Paraiso IL, Revel JS, Stevens JF. Potential use of polyphenols in the battle against COVID-19. Curr Opin Food Sci 2020;32:149\u201355", "ArticleIdList": ["PMC7480644", "32923374"]}, {"Citation": "Goc A, Sumera W, Rath M, Niedzwiecki A. Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions. PLoS ONE 2021;16:e0253489", "ArticleIdList": ["PMC8211150", "34138966"]}, {"Citation": "Reddy MK, Gupta SK, Jacob MR, Khan SI, Ferreira D. Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med 2007;73:461\u20137", "ArticleIdList": ["17566148"]}, {"Citation": "Viuda-Martos M, Fern\u00e1ndez-L\u00f3pez J, P\u00e9rez-\u00c1lvarez J. Pomegranate and its many functional components as related to human health: a review. Compr Rev Food Sci Food Saf 2010;9:635\u201354", "ArticleIdList": ["33467822"]}, {"Citation": "Landete J. Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res Int 2011;44:1150\u201360"}, {"Citation": "Howell AB, D\u2019Souza DH. The pomegranate: effects on bacteria and viruses that influence human health. Evid Based Complement Alternat Med 2013;2013:606212.", "ArticleIdList": ["PMC3671682", "23762148"]}, {"Citation": "Yiu CY, Chen SY, Chang LK, Chiu YF, Lin TP. Inhibitory effects of resveratrol on the Epstein\u2013Barr virus lytic cycle. Molecules 2010;15:7115\u201324", "ArticleIdList": ["PMC6259417", "20948499"]}, {"Citation": "Zhang L, Li Y, Gu Z, Wang Y, Shi M, Ji Y, Sun J, Xu X, Zhang L, Jiang J, Shi W. Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs/NF-\u03baB signaling pathway. PLoS ONE 2015;10:e0116879", "ArticleIdList": ["PMC4333343", "25692777"]}, {"Citation": "Annunziata G, Maisto M, Schisano C, Ciampaglia R, Narciso V, Tenore GC, Novellino E. Resveratrol as a novel anti-herpes simplex virus nutraceutical agent: an overview. Viruses 2018;10:473", "ArticleIdList": ["PMC6164158", "30177661"]}, {"Citation": "Lin CJ, Lin HJ, Chen TH, Hsu YA, Liu CS, Hwang GY, Wan L. Correction: Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression. PLoS ONE 2015;10:e0125288", "ArticleIdList": ["PMC4393289", "25860479"]}, {"Citation": "\nKhaerunnisa S, Kurniawan H, Awaluddin R, Suhartati S, Soetjipto S.\nPotential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study.\nPreprints\n2020:2020030226, https://www.preprints.org/manuscript/202003.0226/v1"}, {"Citation": "\nAdem S, Eyupoglu V, Sarfraz I, Rasul A, Ali M.\nIdentification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA.\nPreprints\n2020:2020030333, https://www.preprints.org/manuscript/202003.0333/v1", "ArticleIdList": ["PMC8957318", "35364308"]}, {"Citation": "Tito A, Colantuono A, Pirone L, Pedone E, Intartaglia D, Giamundo G, Conte I, Vitaglione P, Apone F. Pomegranate peel extract as an inhibitor of SARS-CoV-2 spike binding to human ACE2 receptor (in vitro): a promising source of novel antiviral drugs. Front Chem 2021;9:638187.", "ArticleIdList": ["PMC8114579", "33996744"]}, {"Citation": "Suru\u010di\u0107 R, Tubi\u0107 B, Stojiljkovi\u0107 MP, Djuric DM, Travar M, Grabe\u017e M, \u0160avikin K, \u0160krbi\u0107 R. Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization. Mol Cell Biochem 2021;476:1179\u201393", "ArticleIdList": ["PMC7668668", "33200379"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "27", "Hour": "6", "Minute": "3"}, {"Year": "2023", "Month": "4", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35894129", "PMC9679310", "10.1177/15353702221108915"]}}], "PubmedBookArticle": []}